In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin

Mechanism of Action of and Mechanism of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compound LFF571

(2012) J. A. Leeds et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection

(2011) Ellie J. C. Goldstein et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New target for inhibition of bacterial RNA polymerase: ‘switch region’

(2011) Aashish Srivastava et al.   CURRENT OPINION IN MICROBIOLOGY

Killing kinetics of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile

(2011) F. Babakhani et al.   JOURNAL OF MEDICAL MICROBIOLOGY

The Sequence Alignment/Map format and SAMtools

(2009) H. Li et al.   BIOINFORMATICS

Fast and accurate short read alignment with Burrows-Wheeler transform

(2009) H. Li et al.   BIOINFORMATICS

High Frequency of Rifampin Resistance Identified in an EpidemicClostridium difficileClone from a Large Teaching Hospital

(2009) Scott R. Curry et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial resistance in Clostridium difficile

(2009) Haihui Huang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

SOAP: short oligonucleotide alignment program

(2008) R. Li et al.   BIOINFORMATICS

Velvet: Algorithms for de novo short read assembly using de Bruijn graphs

(2008) D. R. Zerbino et al.   GENOME RESEARCH